Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Microdosing semaglutide can help to kickstart improvements in metabolic and hormonal function while you simultaneously work on supporting your bodys natural processes
We don't believe in "magic pills." We believe in science-backed formulations that respect the body's natural physiology
Smith, C
, ,
Unlike earlier-generation weight-management agents, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormonal receptors: GLP-1 (glucagon-like peptide-1) receptor promotes insulin secretion, reduces appetite, and slows gastric emptying [9] [10] GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin release and may improve fat metabolism [12] [13] Glucagon receptor increases energy expenditure and may reduce hepatic steatosis, as suggested by imaging data (MRI-PDFF) from Phase 2 trials, though this effect requires confirmation in larger studies [2] [5] This triple-agonist mechanism distinguishes retatrutide from agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist), and is thought to produce more pronounced reductions in body weight and improvements in metabolic parameters
This matters because both can affect appetite, fullness, digestion, and medication tolerability
US$ 22.89
US$ 24.35
US$ 24.90
US$ 23.20
US$ 22.55
US$ 22.19
US$ 27.20
